Peptide questions · Pramlintide

How long does pramlintide take to work?

Reviewed Evidence: EstablishedPublished by PepVault

Pramlintide’s onset is first meal (fullness, after-meal glucose), its peak effect comes at 16–52 weeks (weight, HbA1c), and its typical duration is ongoing, by the library’s timeline (backed by clinical trial data).

The timeline’s basis: FDA Symlin label (DailyMed, effective December 2019); Drugs@FDA and the NDC Directory (read November 2026); Aronne 2007; Smith 2008; Kruse 2021. Approved as an add-on to mealtime insulin in diabetes; weight loss is off-label.

Pramlintide week by week

The library places four of its research notes on pramlintide on the days they cover, from day 1 to day 365: 3 on randomized trials and 1 on clinical data.

Day 1 is the first day of a run. Each bar is one of the library’s research notes, placed on the days it covers.

The pramlintide notes by day
WhenThe noteEvidence
Days 1–14 (weeks 1–2)The 15 mcg start (type 1)Randomized trial
Days 1–30 (weeks 1–5)60 mcg, a start and a top doseClinical data
Days 4–365 (weeks 1–53)120 mcg, the type 2 doseRandomized trial
Days 14–365 (weeks 2–53)What it did for weight without insulinRandomized trial
A smiling man in a grey t-shirt in his living room, holding his phone

Model. Individual results vary.

PepVault for iPhone

Track pramlintide in PepVault

Log each dose and your weekly check-ins, and see your own weeks add up.

Download on the App Store

7 days free on the yearly plan for new subscribers.

The pramlintide timeline’s milestones

The library’s timeline for pramlintide marks 5 points from week 1 to week 52, backed by clinical trial data overall.

  • Week 1: Commonly reported: feeling full sooner at meals, with nausea that is highest at the start (label)
  • Week 2: The label steps the dose after at least 3 days without significant nausea
  • Week 4: Commonly reported: smaller meals without trying, and nausea fading for most people
  • Week 16: In a 16-week obesity trial without insulin, weight fell 3.6 kg more than on placebo
  • Week 52: In a 12-month obesity trial, weight stayed off in most dose groups while it came back on placebo

The weeks are the library’s reference timeline from studies and reported use, not a promise of what any one person will notice.

Why pramlintide takes that long

Pramlintide’s half-life is about 48 minutes, so one dose is about 96.9% cleared after 4 hours.

Each dose of pramlintide clears within 4 hours, so its level doesn’t build up from one day to the next: the weeks on the timeline come from repeated doses, not from the compound piling up in the blood.

The notes on pramlintide follow the trials’ dose steps, 15mcg, 60mcg and 120mcg, so the later weeks also describe higher steps than the first ones; these are steps from studies, not a schedule for a person.

Pramlintide against other metabolic & GLP-1 compounds

The library holds an onset-and-peak timeline for 21 metabolic & GLP-1 compounds, pramlintide among them; none of the others shares its onset of first meal (fullness, after-meal glucose).

When metabolic & GLP-1 compounds start to act and peak, by the library’s timelines
CompoundOnsetPeak effect
SemaglutideDays–2 weeks60–68 weeks
TirzepatideDays–2 weeks72+ weeks
RetatrutideDays–2 weeks48+ weeks
DulaglutideDays–2 weeks24–52 weeks (glucose)
ExenatideFirst dose (after-meal glucose)24–30 weeks (HbA1c)
Setmelanotide1–2 weeks (hunger)52 weeks (BMI)
OrforglipronDays–2 weeks72 weeks (trial endpoint)
SurvodutideDays–2 weeks76 weeks (trial endpoint)
MazdutideDays–2 weeks48–60 weeks
PemvidutideDays–2 weeks48+ weeks
CagrilintideDays–2 weeks26–68 weeks (trial endpoints)
PramlintideFirst meal (fullness, after-meal glucose)16–52 weeks (weight, HbA1c)
CagriSemaDays–2 weeks68+ weeks
EloralintideDays–2 weeks48 weeks (phase 2 endpoint)
PetrelintideDays–2 weeks42 weeks (phase 2, still falling)
AmycretinDays–2 weeks36 weeks (longest trial so far)
VK2735Days–2 weeks78 weeks (phase 3 endpoint, not yet read out)
EnicepatideDays–2 weeks48 weeks (phase 2 endpoint, no plateau)
EcnoglutideDays–2 weeks48 weeks (phase 3, no plateau)
EfinopegdutideWeeks24–52 weeks (trial endpoints)
SLU-PP-332Unknown in peopleUnknown in people

Questions people ask

How long does pramlintide take to work?

Pramlintide’s onset is first meal (fullness, after-meal glucose), its peak effect comes at 16–52 weeks (weight, HbA1c), and its typical duration is ongoing, by the library’s timeline (backed by clinical trial data).

When does pramlintide reach its peak effect?

By the library’s timeline, pramlintide’s peak effect comes at 16–52 weeks (weight, HbA1c), backed by clinical trial data.

How long is pramlintide usually run?

The library’s timeline gives pramlintide’s typical duration as ongoing; its cycle note says: FDA-approved for ongoing use with mealtime insulin; its placebo-controlled trials ran 26 to 52 weeks.

What does the library say about the first days on pramlintide?

Its first note on pramlintide, for days 1–14 (weeks 1–2), is “The 15 mcg start (type 1)”, resting on randomized trials.

More on pramlintide

Track it in the app

PepVault for iPhone

Track pramlintide in PepVault

Log each dose and your weekly check-ins, and see your own weeks add up.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo